4D Molecular Therapeutics

General Information


We are a development stage precision gene therapy company dedicated to pioneering the development of targeted therapies based on our next-generation AAV vectors. Our proprietary Therapeutic Vector Evolution platform enables our “disease first” approach to product discovery and development, thereby allowing us to customize our AAV vectors to target specific tissue types associated with the underlying disease.

Employees: 57
Founded: 2013
Contact Information
Address 5858 Horton Street #455, Emeryville, CA 94608, US
Phone Number (510) 505-2680
Web Address http://www.4dmoleculartherapeutics.com
View Prospectus: 4D Molecular Therapeutics
Financial Information
Market Cap
Revenues $13.5 mil (last 12 months)
Net Income $-20.9 mil (last 12 months)
IPO Profile
Symbol DDDD
Exchange NASDAQ
Shares (millions): 0.0
Price range $0.00 - $0.00
Est. $ Volume $100.0 mil
Manager / Joint Managers Goldman Sachs/ Evercore ISI/ William Blair
CO-Managers Chardan
Expected To Trade:
Status: Withdrawn
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change